Induction of Selective Blood-Tumor Barrier Permeability and Macromolecular Transport by a Biostable Kinin B1 Receptor Agonist in a Glioma Rat Model
出版年份 2012 全文链接
标题
Induction of Selective Blood-Tumor Barrier Permeability and Macromolecular Transport by a Biostable Kinin B1 Receptor Agonist in a Glioma Rat Model
作者
关键词
-
出版物
PLoS One
Volume 7, Issue 5, Pages e37485
出版商
Public Library of Science (PLoS)
发表日期
2012-05-22
DOI
10.1371/journal.pone.0037485
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bradykinin Promotes the Chemotactic Invasion of Primary Brain Tumors
- (2011) V. Montana et al. JOURNAL OF NEUROSCIENCE
- Noncanonical intracrine action
- (2011) Richard N. Re et al. Journal of the American Society of Hypertension
- Convection enhanced delivery of carboplatin in combination with radiotherapy for the treatment of brain tumors
- (2010) Weilian Yang et al. JOURNAL OF NEURO-ONCOLOGY
- A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma
- (2010) M. R. Gilbert et al. NEURO-ONCOLOGY
- Selective tumor blood–brain barrier opening with the kinin B2 receptor agonist [Phe8ψ(CH2NH)Arg9]-BK in a F98 glioma rat model: An MRI study
- (2010) Jérôme Côté et al. NEUROPEPTIDES
- Combined Radio- and Chemotherapy of Brain Tumours in Adult Patients
- (2009) C. Nieder et al. CLINICAL ONCOLOGY
- Bradykinin protects against brain microvascular endothelial cell death induced by pathophysiological stimuli
- (2009) Veronica Bovenzi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cerebral Ischemia–Reperfusion Injury in Rats—A 3 T MRI Study on Biphasic Blood–Brain Barrier Opening and the Dynamics of Edema Formation
- (2009) Deepu R Pillai et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas
- (2009) Rolf F. Barth et al. JOURNAL OF NEURO-ONCOLOGY
- Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life
- (2009) Hemant Sarin et al. Journal of Translational Medicine
- Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists
- (2009) J. H. Robben et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recent Advances in Blood–Brain Barrier Disruption as a CNS Delivery Strategy
- (2008) Marc-André Bellavance et al. AAPS Journal
- Expression of tissue and plasma kallikreins and kinin B1 and B2 receptors in lung cancer
- (2008) Jessica Chee et al. BIOLOGICAL CHEMISTRY
- Retinal plasma extravasation in streptozotocin-diabetic rats mediated by kinin B1and B2receptors
- (2008) M Abdouh et al. BRITISH JOURNAL OF PHARMACOLOGY
- The targeted delivery of cancer drugs across the blood–brain barrier: chemical modifications of drugs or drug-nanoparticles?
- (2008) Lucienne Juillerat-Jeanneret DRUG DISCOVERY TODAY
- Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation
- (2008) Martin Savard et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Strategies to advance translational research into brain barriers
- (2008) Edward Neuwelt et al. LANCET NEUROLOGY
- Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma model
- (2008) Kristoph Jahnke et al. NEURO-ONCOLOGY
- Structure–activity relationships of novel peptide agonists of the human bradykinin B2 receptor
- (2008) Simon Bélanger et al. PEPTIDES
- Novel kinin B1 receptor agonists with improved pharmacological profiles
- (2008) Jérôme Côté et al. PEPTIDES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More